Meadow Brook Investment Advisors LLC Syndax Pharmaceuticals Inc Transaction History
Meadow Brook Investment Advisors LLC
- $106 Billion
- Q2 2024
A detailed history of Meadow Brook Investment Advisors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 1,700 shares of SNDX stock, worth $32,521. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,700
Previous 1,700
-0.0%
Holding current value
$32,521
Previous $40.5 Million
13.74%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
202Shares Held
87.1MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$151 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$140 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$109 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$91.8 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$74.4 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.08B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...